Sarah McAleer, MD
Urology · Manchester, NHNPI 1265531198
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.4% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Medtronic at 28.6% of the total. Reporting peaked in 2019 at $181 and has fallen 84.6% since, to $28 in 2025. That places this record below the midpoint for urology clinicians in NH, where the typical reported total is $863.
Across 14 payments — averaging $40.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$164
- AbbVie$150
- Teleflex LLC$80
- Urogen Pharma, Inc.$66
- Pfizer$42
- Boston Scientific$18
- plus $52 from 4 others
What the payments were for
- Food & beverage$55897%
- Education$153%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 3 | $164 |
| AbbVie | 2 | $150 |
| Teleflex LLC | 1 | $80 |
| Urogen Pharma, Inc. | 1 | $66 |
| Pfizer | 2 | $42 |
| Boston Scientific | 1 | $18 |
| Myriad Genetic Laboratories, Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $15 |
| Coloplast | 1 | $11 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lupron Depot$123
How this compares
$573 in reported general payments places this provider in the 35th percentile of 61 urology providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 94 | $58,696 |
| GemtesaVibegron | 20 | $15,812 |
| Solifenacin Succinate | 77 | $7,569 |
| Mirabegron ErMirabegron | 15 | $5,536 |
| Methenamine Hippurate | 59 | $5,200 |
| Tamsulosin Hcl | 358 | $5,028 |
| Tolterodine Tartrate ErTolterodine Tartrate | 26 | $3,050 |
| Estradiol | 39 | $2,711 |
| Tadalafil | 12 | $1,975 |
| Oxybutynin Chloride ErOxybutynin Chloride | 77 | $1,968 |
| NitrofurantoinNitrofurantoin Macrocrystal | 24 | $1,817 |
| Finasteride | 145 | $1,446 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 12 | $1,183 |
| Cephalexin | 113 | $720 |
| Oxybutynin Chloride | 42 | $302 |
Paid to pharmacies, not to this prescriber.
Other urology in Manchester
- Jason AkermanManchester$53K
- John MunozManchester$15K
- Samuel SnipesManchester$6K
- Christopher GirasoleManchester$5K
- Cyrus NobleManchester$4K
- William SelleckManchester$960
- Stephen SmithManchester$78
- Armando LopezManchester$6
- Martin GrossKeene$172K
- Ramiro Madden-FuentesConcord$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.